EU regulator ‘scrutinising’ AstraZeneca jab’s safety

The agency is trying ‘to understand if there are any specific cluster of cases around the certain type of pathologies or background stages, medical stages of the subjects, in order to refine the benefit-risk options’.

Read the full story: Read More